Facility of the Future

Impact of Innovative Technology and Continuous Manufacturing

Session 501
Facilities and Equipment Track

This session will provide you with the current trends in the development, design, construction and operation of drug manufacturing facilities of the future. There will be a twenty minute presentation on specific progress areas.

At the conclusion of this session, participants will be able to:

Accurately plan and develop capital authorization requests and appropriation plans for future design and construction projects
Successfully implement current technology trends in future facility plans
Operate and maintain their current facilities better utilizing technology updates
Deliver capital projects through the use of efficient project delivery methods and technology methods
Understand code requirements and how they impact their specific companies and facilities

Leaders

Speakers

Jeff Campie, USA
Richard Forsyth, Senior Consultant, Hyde Engineering + Consulting, USA
Nigel Hamilton, Global Quality, Strategy and Process Excellence, Sanofi Aventis, United Kingdom
Aisling Horan, Validation Scientist, Alkermes Plc, Ireland
Edwin Melendez, Principle Consultant, Parexel, USA
Mark O'Reilly, Director Engineering, Alkermes Pharma Ireland Ltd, Ireland
Kimberly Ray, A. Director Project Mgmt, Oso Biopharmaceuticals Mfg LLC, USA
Julian Wilkins, Vice President, PharmaConsult US Inc, USA
Paul Wreglesworth, Independent Consultant, United Kingdom

Who Should Attend

Manufacturing / Operations
Service Providers
Commissioning, Qualification and Validation Professionals
Quality and Compliance Professionals
Engineers
Regulators

Communities of Practice Members that will Benefit

API
Biotech
Critical Utilities
Disposables
Eng Standards Benchmarking
GAMP
Good Control Lab Practices
HVAC
Operations Management
OSD
Product Process Development
Project Management
Sustainable Facilities

More information on ISPE's Communities of Practice